Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing.

摘要

This is the authors final draft of the version published as International Journal of Canacer, 2008, 122 (8), pp.1810-9. The published online version can be accessed at \udhttp://www3.interscience.wiley.com/journal/117860573/abstract.